Video

Debating Testing or Treatment for Gastroparesis Part 2

Author(s):

As part of the American Gastroenterological Association's Winter Postgraduate Course, William D. Chey, MD, AGAF, from the University of Michigan, and Michael Camilleri, MD, AGAF, from the Mayo Clinic, discussed the best treatment course for patients with gastroparesis.

As part of the American Gastroenterological Association's Winter Postgraduate Course, William D. Chey, MD, AGAF, from the University of Michigan, and Michael Camilleri, MD, AGAF, from the Mayo Clinic, discussed the best treatment course for patients with gastroparesis.

In part 2 of our series on the debate Camilleri explains why testing can be beneficial even when the results and the resulting treatments are not as reliable as some doctors would like them to be.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.